These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 9118874)

  • 1. P53 mutations associated with breast, colorectal, liver, lung, and ovarian cancers.
    Lasky T; Silbergeld E
    Environ Health Perspect; 1996 Dec; 104(12):1324-31. PubMed ID: 9118874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p53 mutations in breast cancer.
    Coles C; Condie A; Chetty U; Steel CM; Evans HJ; Prosser J
    Cancer Res; 1992 Oct; 52(19):5291-8. PubMed ID: 1394133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Searching for microsatellite mutations in coding regions in lung, breast, ovarian and colorectal cancers.
    Forgacs E; Wren JD; Kamibayashi C; Kondo M; Xu XL; Markowitz S; Tomlinson GE; Muller CY; Gazdar AF; Garner HR; Minna JD
    Oncogene; 2001 Feb; 20(8):1005-9. PubMed ID: 11314036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A specific spectrum of p53 mutations in lung cancer from smokers: review of mutations compiled in the IARC p53 database.
    Hernandez-Boussard TM; Hainaut P
    Environ Health Perspect; 1998 Jul; 106(7):385-91. PubMed ID: 9637795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p53 gene mutations inside and outside of exons 5-8: the patterns differ in breast and other cancers.
    Hartmann A; Blaszyk H; McGovern RM; Schroeder JJ; Cunningham J; De Vries EM; Kovach JS; Sommer SS
    Oncogene; 1995 Feb; 10(4):681-8. PubMed ID: 7862445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. G:C > A:T mutations and potential epigenetic regulation of p53 in breast cancer.
    Kouidou S; Malousi A; Kyventidis A; Fragou A; Maglaveras N
    Breast Cancer Res Treat; 2007 Dec; 106(3):351-60. PubMed ID: 17505880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutability of p53 hotspot codons to benzo(a)pyrene diol epoxide (BPDE) and the frequency of p53 mutations in nontumorous human lung.
    Hussain SP; Amstad P; Raja K; Sawyer M; Hofseth L; Shields PG; Hewer A; Phillips DH; Ryberg D; Haugen A; Harris CC
    Cancer Res; 2001 Sep; 61(17):6350-5. PubMed ID: 11522624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations in the tumor suppressor gene p53 in human liver cancer induced by alpha-particles.
    Andersson M; Jönsson M; Nielsen LL; Vyberg M; Visfeldt J; Storm HH; Wallin H
    Cancer Epidemiol Biomarkers Prev; 1995; 4(7):765-70. PubMed ID: 8672994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. "Hot spots" mutation analysis of p53 gene in gastrointestinal cancers by amplification of naturally occurring and artificially created restriction sites.
    Chen PH; Lin SY; Wang CK; Chen YJ; Chen TC; Chang JG
    Clin Chem; 1993 Oct; 39(10):2186-91. PubMed ID: 7691445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatocellular carcinoma p53 G > T transversions at codon 249: the fingerprint of aflatoxin exposure?
    Lasky T; Magder L
    Environ Health Perspect; 1997 Apr; 105(4):392-7. PubMed ID: 9189703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of p53 mutations in colorectal liver metastases and correlation with clinical parameters.
    Tullo A; D'Erchia AM; Honda K; Mitry RR; Kelly MD; Habib NA; Saccone C; Sbisà E
    Clin Cancer Res; 1999 Nov; 5(11):3523-8. PubMed ID: 10589767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benzo[a]pyrene-induced mutagenesis of p53 hot-spot codons 248 and 249 in human hepatocytes.
    Cherpillod P; Amstad PA
    Mol Carcinog; 1995 May; 13(1):15-20. PubMed ID: 7766306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p53 mutations in human cancers.
    Hollstein M; Sidransky D; Vogelstein B; Harris CC
    Science; 1991 Jul; 253(5015):49-53. PubMed ID: 1905840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Detection and sequence analysis of the p53 gene mutation in epithelial ovarian cancer].
    Guan X; Lang J; Bian M
    Zhonghua Fu Chan Ke Za Zhi; 1998 Mar; 33(3):165-7. PubMed ID: 10682487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spectrum of mutation and frequency of allelic deletion of the p53 gene in ovarian cancer.
    Kohler MF; Marks JR; Wiseman RW; Jacobs IJ; Davidoff AM; Clarke-Pearson DL; Soper JT; Bast RC; Berchuck A
    J Natl Cancer Inst; 1993 Sep; 85(18):1513-9. PubMed ID: 8360934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 1995 Deichmann Lecture--p53 tumor suppressor gene: at the crossroads of molecular carcinogenesis, molecular epidemiology and cancer risk assessment.
    Harris CC
    Toxicol Lett; 1995 Dec; 82-83():1-7. PubMed ID: 8597035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The TP53 codon 72 polymorphism may affect the function of TP53 mutations in breast carcinomas but not in colorectal carcinomas.
    Langerød A; Bukholm IR; Bregård A; Lønning PE; Andersen TI; Rognum TO; Meling GI; Lothe RA; Børresen-Dale AL
    Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1684-8. PubMed ID: 12496062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does a genotoxic carcinogen contribute to human breast cancer? The value of mutational spectra in unravelling the aetiology of cancer.
    Biggs PJ; Warren W; Venitt S; Stratton MR
    Mutagenesis; 1993 Jul; 8(4):275-83. PubMed ID: 8377645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carcinogen-specific mutations in the p53 tumor suppressor gene in lung cancer.
    Kandioler D; Foedinger M; Mueller MR; Eckersberger F; Mannhalter C; Wolner E
    J Thorac Cardiovasc Surg; 1994 Apr; 107(4):1095-8. PubMed ID: 8159032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concomitant point mutation of tumor suppressor gene p53 and oncogene c-N-ras in malignant neuroendocrine pancreatic tumor.
    Hrasćan R; Pavelić K; Pavicić D; Krizanac S; Stajcer-Sittić V; Pecur L; Spaventi S; Klimpfinger M; Pavelić J
    Anticancer Res; 1996; 16(6B):3761-6. PubMed ID: 9042254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.